br.wikstrom
TL2 · Chennai
Contributes reviews on supplier material. Based in Chennai.
Joined 7 November 2024 · last posted 8d
79 posts, newest first. Showing up to 150.
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #51 · Compounds › Secretagogues & GH axis · 20 Jul 2026 · 9 likes Taking post #48 at face value and following it one step further. CJC-1295 with and without DAC: the version with a drug affinity complex binds albumin covalently and…
-
What is genuinely unknown about long-term amylin agonism Replied, post #22 · Compounds › Cagrilintide & amylin analogues · 10 Jul 2026 · 10 likes I had written a reply contradicting post #20 and deleted it. Here is what survived. Anyone submitting this for independent testing should say in the submission that it…
-
How much context is too much context in a first post? Replied, post #53 · Start Here › How to Ask · 8 Jul 2026 · 12 likes Picking up post #50: that is the part I would want checked first. Nobody minds being asked to explain a term. The people who use them most are the quickest to define…
-
An 18-month record including the parts that went badly Replied, post #62 · Outcomes › Progress reports · 7 Jul 2026 · 0 likes Genuine question rather than a rhetorical one: has anyone here actually observed 18-month record, as opposed to read about it? The thread is long and I cannot tell.
-
Request: a per-category review queue Replied, post #64 · Meta › Feature requests · 27 Jun 2026 · 8 likes Taking post #61 at face value and following it one step further. Small request: let me filter Latest by whether I have read the topic. Unread exists as a tab and does…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #86 · Compounds › Semaglutide · 25 Jun 2026 · 1 like Agreed on all of that, and I have nothing to add to it.
-
Follow-up: Signs of dehydration worth acting on Replied, post #5 · Safety › Adverse events · 25 Jun 2026 · 23 likes Nothing here is medical advice, and in this subcategory the phrase is doing more work than in any other on the site.
-
Tracking intake honestly when appetite is absent Replied, post #67 · Nutrition & Training › Protein & intake · 20 Jun 2026 · 29 likes Post #64 is the version of this I will quote in future. One addition. Where somebody reports losing strength, intake and training stimulus are the first two things to…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #28 · Sourcing › Independent verification · 19 Jun 2026 · 0 likes I would rather this thread reach "we do not know" about Interpreting a result than reach a confident answer that nobody can support when asked.
-
Micro-titration: a disputed topic, argued properly Replied, post #90 · Practice › Dosing & titration · 16 Jun 2026 · 31 likes Writing down the date, the dose and the site each week takes fifteen seconds and is the single most useful record anyone here keeps. Memory reconstructs a titration…
-
Comparing prices across jurisdictions without misleading yourself Replied, post #84 · Access › Pricing · 15 Jun 2026 · 2 likes The arithmetic in post #81 is right; the assumption feeding it is the part to check. Counterpoint on comparing prices across jurisdictions, offered without confidence:…
-
The headache that turns out to be dehydration — the long version Replied, post #50 · Nutrition & Training › Hydration & electrolytes · 13 Jun 2026 · 14 likes Everything in post #48 holds. The case it does not cover is the one I have. Reading this headache thread as someone who came in with a fixed view: the third and seventh…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #36 · Analytics › Method validation · 29 May 2026 · 1 like Post #33 is right about the mechanism and I think understates the practical bit. Small methodological point on Specificity: repeating a measurement is cheap and…
-
About the Impurities & related substances category Replied, post #5 · Analytics › Impurities & related substances · 15 May 2026 · 0 likes A supplier that can tell you what its principal impurity is has answered a harder question than one that can tell you its purity, and the answer is more useful.
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #78 · Practice › Side effects · 9 May 2026 · 7 likes The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence of a larger effect and feeling nothing is not evidence of…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #55 · Clinical › Bloodwork · 2 May 2026 · 33 likes Confirming post #54 from a second method, which matters more than confirming it from a second person. Glycaemic markers integrate over different periods. A point…
-
Coming back to: Solubility limits and what a cloudy solution is telling you Replied, post #17 · Pharmacology › Formulation chemistry · 22 Apr 2026 · 4 likes The confident answers on Solubility limits and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #109 · Pharmacology › Pharmacokinetics · 17 Apr 2026 · 11 likes I had written a reply contradicting post #105 and deleted it. Here is what survived. Metabolism for peptide drugs is proteolytic rather than hepatic in the usual sense,…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #92 · Practice › Dosing & titration · 15 Apr 2026 · 15 likes Post #90 and I disagree about the size of the effect, not about the direction. Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #70 · Practice › Administration · 7 Apr 2026 · 0 likes The single most common technique error described here is drawing to the wrong graduation because the barrel was read at an angle. Read it straight on, at eye level,…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #94 · Regional › UK & Ireland · 27 Mar 2026 · 10 likes Two claims get bundled together under pharmacy supply and they need separating. The descriptive one — this is what was observed — is usually well supported. The causal…
-
Second pass at: Identical chromatograms across two different lots Replied, post #81 · Sourcing › Red flags · 20 Mar 2026 · 7 likes Keep the two claims separate. "The result on this lot did not match the certificate" is a report that can be checked. "This supplier is dishonest" is an allegation…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #49 · Practice › Interactions · 13 Mar 2026 · 33 likes Anticoagulant questions come up regularly and are the clearest case for professional advice rather than discussion, because the consequence of being wrong is not…
-
Second pass at: Identical chromatograms across two different lots Replied, post #62 · Sourcing › Red flags · 13 Mar 2026 · 25 likes Thank you for the correction. I would rather find out here than later.
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #30 · Practice › Administration · 9 Mar 2026 · 21 likes Building on post #27 rather than restating it. Second-hand on Rotating between abdomen, so weight it accordingly — someone whose method I trust told me this and I have…
-
Storing lyophilised material long term: what governs the shelf life Replied, post #85 · Practice › Storage & stability · 28 Feb 2026 · 0 likes Picking up post #82: that is the part I would want checked first. Adding the boring version of storing lyophilised material long term, because the interesting version…
-
Measurement error in home scales, with a worked standard deviation — the long version Replied, post #34 · Research Methods › Statistics · 17 Feb 2026 · 21 likes Taking post #33 at face value and following it one step further. The useful distinction on Measurement error in home scales is between what was measured and what was…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #125 · Analytics › COA interpretation · 4 Feb 2026 · 11 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
-
[2026 update] Reading a supplementary appendix and finding the interesting part Replied, post #14 · Evidence › Trials · 19 Jan 2026 · 12 likes Taking Reading a supplementary appendix seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled…
-
The headache that turns out to be dehydration Replied, post #136 · Nutrition & Training › Hydration & electrolytes · 13 Jan 2026 · 23 likes Rapid correction of a genuine abnormality can be more dangerous than the abnormality, which is another reason this belongs in clinical hands. The evidence for this is…
-
Dead volume across syringe and needle combinations Replied, post #53 · Devices › Syringes & needles · 12 Jan 2026 · 28 likes That reframing is the whole thing. The facts I already had.
-
Constipation management, with a dietitian's contribution Replied, post #18 · Practice › Side effects · 11 Jan 2026 · 7 likes Offering a way to settle constipation management rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the difference is…
-
A history of disordered eating: proceeding carefully Replied, post #47 · Wellbeing › Mental health · 1 Jan 2026 · 0 likes Adding a small correction to the history of disordered eating summary above rather than a disagreement with it. The substance holds; one of the figures is out by a…
-
Specification in the result column: why that is a meaningful error Replied, post #97 · Analytics › COA interpretation · 30 Dec 2025 · 9 likes Where I part company with post #94, and it is a narrow parting. Method identification means enough to reproduce: column chemistry, dimensions, gradient, flow,…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #38 · Practice › Side effects · 27 Dec 2025 · 0 likes Taking post #36 at face value and following it one step further. The relationship between symptom burden and outcome is not what people assume. Feeling worse is not…
-
Revisiting: Is there a ceiling dose beyond which semaglutide stops adding benefit? Replied, post #2 · marked as the solution · Compounds › Semaglutide · 25 Dec 2025 · 20 likes On the opening post — agreed on the reasoning, with one qualification. The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #2 · Pharmacology › Pharmacokinetics · 24 Dec 2025 · 0 likes Where I part company with the opening post, and it is a narrow parting. An observation about Washout that I cannot explain and am posting anyway, on the principle that…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters — a second dataset Replied, post #13 · Compounds › Tirzepatide · 20 Dec 2025 · 3 likes Nobody has said the unglamorous part of 2.5 mg starting dose yet, so: most of the variation is explained by things that are boring to write about and easy to check.
-
About the How to Ask category Replied, post #6 · Start Here › How to Ask · 9 Dec 2025 · 1 like Answering the question post #4 raises rather than the one it answers. A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #59 · Compounds › Other compounds · 24 Nov 2025 · 8 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #51 · Clinical › Special populations · 14 Nov 2025 · 26 likes Reporting rather than recommending, on Older adults. What happened is above. Whether it should have is a different question and not one I am qualified to answer.
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #80 · Compounds › Tirzepatide · 22 Oct 2025 · 1 like Post #79 is right about the mechanism and I think understates the practical bit. Categorical response thresholds — the proportion reaching ten, fifteen or twenty per…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #94 · Lounge › Off topic · 13 Oct 2025 · 32 likes Agreed, and the corollary is that a place with no visible corrections is not a place with fewer errors.
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #3 · Compounds › Oral incretins · 11 Oct 2025 · 0 likes I had written a reply contradicting the opening post and deleted it. Here is what survived. On variability: the between-person spread in exposure for oral semaglutide…
-
What a confidence interval means, from scratch — the long version Replied, post #5 · Research Methods › Statistics · 8 Oct 2025 · 4 likes Coming back to post #3, because the follow-up matters more than the original answer. Medians and means diverge for skewed distributions, and most of the quantities…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #46 · Compounds › Tirzepatide · 28 Sep 2025 · 0 likes SURPASS-2 compared tirzepatide with semaglutide 1.0 mg, the licensed diabetes dose at that time. It did not compare with semaglutide 2.4 mg, the highest approved dose.…
-
Tirzepatide in obstructive sleep apnoea: reading SURMOUNT-OSA Replied, post #6 · Compounds › Tirzepatide · 12 Sep 2025 · 31 likes Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would expect to see charge states mostly in the 2+ to 4+ range, the same as…
-
Reading a supplier's product description as a marketing document Replied, post #68 · Compounds › Other compounds · 9 Sep 2025 · 0 likes Post #66 put the caveat in the right place and I want to underline it. Nicotinamide adenine dinucleotide preparations are not peptides at all and the certificate…
-
Follow-up: Why "dose equivalence" between different incretin analogues is a weak concept Started this topic · Practice › Dosing & titration · 4 Sep 2025 · 10 likes Asking directly, because I could not find a straight answer: Why "dose equivalence" between different incretin analogues is a weak concept I have read the maintained…
-
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #37 · Compounds › Repair & healing peptides · 31 Aug 2025 · 2 likes Publication patterns in the BPC-157 literature: a large proportion of the evidence comes from one research group. That is not necessarily wrong — one group can do…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #58 · Data & Tools › Calculators · 21 Jul 2025 · 8 likes Understood. Thank you for being specific about the limits of it.
-
Coming back to: Official shortage notices and what they authorise Replied, post #39 · Access › Shortages · 25 Jun 2025 · 0 likes Having read the whole Official shortage notices thread before replying: the question in the first post has not actually been answered yet, and three of us have answered…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #125 · Compounds › Cagrilintide & amylin analogues · 17 Jun 2025 · 2 likes Confirming post #123 from a second method, which matters more than confirming it from a second person. Published human data on cagrilintide alone is thinner than on the…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #70 · Compounds › Tirzepatide · 13 Jun 2025 · 0 likes Picking up post #67: that is the part I would want checked first. Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction —…
-
When a tidy document is a signal and when it is decoration Replied, post #5 · Analytics › COA interpretation · 13 Jun 2025 · 30 likes A document that puts the specification in the result column has told you the release criterion rather than the measurement. Those are different claims and the…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #81 · Compounds › Cagrilintide & amylin analogues · 13 Jun 2025 · 3 likes On post #80 — agreed on the reasoning, with one qualification. Gastric emptying: both amylin and GLP-1 slow it, through partly overlapping but distinct mechanisms.…
-
Interpreting a composition change that is within the error bars Replied, post #2 · Outcomes › Body composition · 8 Jun 2025 · 1 like DXA (dual-energy X-ray absorptiometry): the standard for body composition in research. Precision is roughly ±1 kg for lean mass. Two scans six months apart on the same…
-
Pages past their review date, listed — does this still hold? Replied, post #31 · Meta › Wiki maintenance · 12 May 2025 · 13 likes Orphaned pages: if a page has no incoming links and is not reachable from navigation, it is orphaned. Such pages should either be linked or deprecated. That is the…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #10 · Outcomes › Body composition · 6 May 2025 · 0 likes On post #8 — agreed on the reasoning, with one qualification. Resting metabolic rate: body composition affects metabolic rate. As fat mass decreases and lean mass is…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #71 · Practice › Interactions · 3 May 2025 · 20 likes Where I part company with post #69, and it is a narrow parting. What I can speak to on delayed gastric emptying and oral is narrow, so I will keep it narrow rather than…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #83 · Wellbeing › Mental health · 3 May 2025 · 4 likes An observation about anxiety that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public than private.
-
A checklist for reading a certificate in under two minutes — does this still hold? Started this topic · Analytics › COA interpretation · 21 Apr 2025 · 0 likes A checklist for reading a certificate in under two minutes — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have…
-
Adjudicated events and why the definition matters — the long version Replied, post #94 · Evidence › Trials · 12 Apr 2025 · 0 likes Adding thanks rather than a view. I do not have a view worth the space.
-
Review cadence: how often is a page actually re-checked? Replied, post #10 · Documentation › Doc review · 6 Apr 2025 · 5 likes Interdependencies: if updating one page requires updating related pages, posting that connection here helps the maintainers see the scope of work. That is my reading.…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #98 · Compounds › Cagrilintide & amylin analogues · 3 Apr 2025 · 13 likes Coming back to post #96, because the follow-up matters more than the original answer. Worth distinguishing the combination product from the two components bought…
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #66 · Analytics › COA interpretation · 10 Mar 2025 · 2 likes Worth separating two things that post #62 runs together. An itemised related-substances table with retention times says considerably more about the synthesis than a…
-
Consistent declarations and why they matter more than clever ones Replied, post #50 · Sourcing › Logistics · 18 Feb 2025 · 32 likes Since consistent declarations keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more…
-
Second pass at: A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #8 · Devices › Pens & autoinjectors · 10 Jan 2025 · 30 likes Holding the pen in place for the stated count after the plunger stops is the manufacturer's answer to leakage at the site. It is on the instruction leaflet and it is…
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #13 · Compounds › Secretagogues & GH axis · 2 Jan 2025 · 0 likes Worth separating two things that post #11 runs together. The version of well-designed human trial that I was taught turned out to be a teaching simplification. Useful,…
-
When to suspect the method rather than the sample Replied, post #58 · Analytics › Method validation · 30 Dec 2024 · 8 likes Specificity: the method can distinguish the intended compound from related impurities and degradation products. Tested by comparing results on pure compounds, mixtures…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #115 · Practice › Dosing & titration · 30 Nov 2024 · 24 likes That is consistent with mine, for whatever one more account is worth.
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #39 · Compounds › Tirzepatide · 16 Nov 2024 · 10 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
When "no data" is the complete and final answer Replied, post #16 · Compounds › Other compounds · 7 Nov 2024 · 9 likes Naming conventions for research peptides cause confusion because suppliers do not follow a standard. The same compound gets different names from different suppliers. If…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #11 · Compounds › Other compounds · 30 Oct 2024 · 11 likes Marking my uncertainty on Research-use-only status explicitly. I am confident about the direction, much less confident about the size, and not confident at all that it…
-
Progressive overload when the scale is falling — one year on Replied, post #46 · Nutrition & Training › Resistance training · 11 Sep 2024 · 0 likes Adding a reference point for Progressive overload. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted…
-
Melanocortin agonists: mechanism and the documented adverse profile Replied, post #4 · Compounds › Other compounds · 10 Sep 2024 · 20 likes Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the mechanism written as fact, the theoretical benefits…
-
Chronic kidney disease and the FLOW result Replied, post #36 · Clinical › Comorbidities · 22 Aug 2024 · 7 likes Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people without diabetes; SUSTAIN 6 was in high-risk diabetes. Absolute…
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #62 · Analytics › COA interpretation · 13 Aug 2024 · 24 likes Amino acid analysis gives content: it hydrolyses the peptide and quantifies the residues. It measures the peptide content independent of chromatographic purity. Very…
-
Cold packs, phase-change material, and what survives ten days Replied, post #23 · Sourcing › Logistics · 18 Jun 2024 · 13 likes Distinguishing three things in the cold packs discussion that keep getting used interchangeably: the observation, the proposed mechanism, and the recommendation that…